These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 3996113)

  • 1. [Leukocyte adherence inhibition assay for the diagnosis of bladder cancer].
    Xu JN; Li YT; Zhang ZY
    Zhonghua Wai Ke Za Zhi; 1985 Mar; 23(3):148-51, 190. PubMed ID: 3996113
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effect of the serum blocking factor assay in the diagnosis and treatment of bladder cancer].
    Xu JN; Li YT; Zhang ZY
    Zhonghua Wai Ke Za Zhi; 1985 Aug; 23(8):453-6, 508. PubMed ID: 4092537
    [No Abstract]   [Full Text] [Related]  

  • 3. Transitional cell carcinoma: circulating tumor antigen correlated with presence/absence of tumor (leukocyte migration assay).
    Bowen JG
    Natl Cancer Inst Monogr; 1978 Dec; (49):245-7. PubMed ID: 748778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leukocyte migration inhibition in vitro in bladder carcinoma.
    Lavergne JA; Lamm DL; Radwin HM; Harrington JT
    Cancer Res; 1979 Jun; 39(6 Pt 1):1985-8. PubMed ID: 445398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The leukocyte adherence inhibition assay as a measure of antitumor immunity in bladder cancer patients.
    Ramsey EW; Malcolm AJ
    J Urol; 1981 Nov; 126(5):600-3. PubMed ID: 7029006
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Initial evaluation of the bladder tumor antigen test in superficial bladder cancer.
    D'Hallewin MA; Baert L
    J Urol; 1996 Feb; 155(2):475-6. PubMed ID: 8558639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Tumor bladder antigen (TBA). A new method for the diagnosis and detection of recurrence of bladder cancer].
    Escaf Barmadah S; Martín Benito JL; Fernández Gómez JM; San Martín Blanco A; Pérez Gracia FJ; Rodríguez Martínez JJ
    Arch Esp Urol; 1998 Mar; 51(2):129-36. PubMed ID: 9586309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Studies on the cellular immune response in patients with urinary bladder carcinoma. IV. Leukocyte adherence inhibition tests and leukocyte migration inhibition test (author's transl)].
    Nishio S; Horii A; Morikawa Y; Kawakita J; Nishijima T; Maekawa M
    Nihon Hinyokika Gakkai Zasshi; 1979 Mar; 70(3):305-16. PubMed ID: 374815
    [No Abstract]   [Full Text] [Related]  

  • 9. Cellular immunity in bladder cancer patients.
    Guinan P; McKiel C; Flanagan M; Bhatti R; Pessis D; Ablin RJ
    J Urol; 1978 Jun; 119(6):747-9. PubMed ID: 660759
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lewis X antigen immunostaining in the diagnosis of transitional cell carcinoma.
    Loy TS; Alexander CJ; Calaluce RD
    Mod Pathol; 1995 Aug; 8(6):587-90. PubMed ID: 8532688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advances in diagnosis and therapy of transitional cell carcinoma of the bladder.
    Lerner SP
    Urol Oncol; 2006; 24(4):324-5. PubMed ID: 16818186
    [No Abstract]   [Full Text] [Related]  

  • 12. FISH--a new noninvasive method for the diagnosis of urinary bladder carcinomas.
    Lübbe L; Nowack R; May M; Ullmann K; Gunia S; Kaufmann O; Hakenberg O; Muche J; Hoschke B
    Clin Lab; 2004; 50(7-8):395-402. PubMed ID: 15330506
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ultrasound and the diagnosis of transitional cell carcinoma of the bladder.
    Bellina PV
    J La State Med Soc; 1981 Jul; 133(7):107-8. PubMed ID: 7276694
    [No Abstract]   [Full Text] [Related]  

  • 14. Combined assay of CYFRA21-1, telomerase and vascular endothelial growth factor in the detection of bladder transitional cell carcinoma.
    Bian W; Xu Z
    Int J Urol; 2007 Feb; 14(2):108-11. PubMed ID: 17302565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multitarget fluorescence in situ hybridization assay detects transitional cell carcinoma in the majority of patients with bladder cancer and atypical or negative urine cytology.
    Skacel M; Fahmy M; Brainard JA; Pettay JD; Biscotti CV; Liou LS; Procop GW; Jones JS; Ulchaker J; Zippe CD; Tubbs RR
    J Urol; 2003 Jun; 169(6):2101-5. PubMed ID: 12771727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Accuracy of the ImmunoCyt assay in the diagnosis of transitional cell carcinoma of the urinary bladder.
    Feil G; Zumbrägel A; Päulgen-Nelde HJ; Hennenlotter J; Maurer S; Krause S; Bichler KH; Stenzl A
    Anticancer Res; 2003; 23(2A):963-7. PubMed ID: 12820331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The BTA stat test in the follow-up for bladder cancer].
    Gutiérrez Baños JL; Martín García B; de Diego Rodríguez E; Hernández Rodríguez R; Portillo Martín JA; Correas Gómez MA; del Valle Schaan JI; Roca Edreira A; Rado Velázquez MA
    Arch Esp Urol; 1999 Oct; 52(8):856-61. PubMed ID: 10589117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Erythrocyte adherence test for identifying A, B and O(H) antigens in preneoplastic and neoplastic lesions of the bladder urothelium].
    Bertoni F; Mattarozzi A; Bacchini P
    Pathologica; 1982; 74(1032):449-61. PubMed ID: 7162862
    [No Abstract]   [Full Text] [Related]  

  • 19. Autoantibodies against P53 protein in patients with transitional cell carcinoma of the bladder.
    Sanchez-Carbayo M; Chulia MT; Niveiro M; Aranda I; Mira A; Soria F
    Anticancer Res; 1999; 19(4C):3531-7. PubMed ID: 10629648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The diagnosis and monitoring of transitional cell cancer of the urinary tract through nuclear matrix protein 22].
    Chen HQ; Han CZ; Du LL; Cui Y; Pang DZ; Jing JX; Zhao XW; Tian BG; Mi ZG
    Zhonghua Yu Fang Yi Xue Za Zhi; 2007 Jun; 41 Suppl():84-6. PubMed ID: 17767866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.